Loncastuximab tesirine

Tax included
Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma.
MedChemExpress 
HY-P99349

Data sheet

Size
Multiple sizes
Reactivity
Antibody-Drug Conjugates (ADCs); Apoptosis
Application
Cancer-programmed cell death
CAS
1879918-31-6